Tirzepatide is actively studied in research on dual incretin receptor pharmacology, adipose tissue biology, beta-cell preservation, NASH resolution, obstructive sleep apnea, heart failure with preserved ejection fraction (HFpEF), and polycystic kidney disease
The activity of GHK-Cu is studied exclusively within controlled in vitro, preclinical and laboratory research environments
Caution: Consult physician if pregnant/nursing, taking medication, or have a medical condition
Men with obesity or type 2 diabetes should speak to their GP about currently NICE-approved options such as semaglutide (Wegovy) or tirzepatide (Mounjaro) while trials continue
Pull the needle cover straight off the needle and insert the needle straight through the rubber stopper